Exact Mass: 476.18417980000004

Exact Mass Matches: 476.18417980000004

Found 500 metabolites which its exact mass value is equals to given mass value 476.18417980000004, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Kanokoside A

C21H32O12 (476.1893672)

1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate

1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoic acid

C28H28O7 (476.1834938)

1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate is found in herbs and spices. 1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate is a constituent of Myristica fragrans (nutmeg). Constituent of Myristica fragrans (nutmeg). 1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate is found in herbs and spices.

Vemlidy

L-Alanine, N-((S)-(((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)phenoxyphosphinyl)-, 1-methylethyl ester

C21H29N6O5P (476.1936954)

lytanthosalin

Isoscrophularioside

C24H28O10 (476.16823880000004)

Matteucinol 7-O-glucoside

(S) -2,3-Dihydro-7- (beta-D-glucopyranosyloxy) -5-hydroxy-2- (4-methoxyphenyl) -6,8-dimethyl-4H-1-benzopyran-4-one

Glu Asp Val Asp

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-4-carboxybutanamido]-3-carboxypropanamido]-3-methylbutanamido]butanedioic acid

C18H28N4O11 (476.1754498)

Gly Asp Ala Asn Thr

C17H28N6O10 (476.18668279999997)

C24H28O10_Spiro[furan-3(2H),1(4H)-naphthalene]-4a,5(5H)-dicarboxylic acid, 6-(acetyloxy)-5-(3-furanyl)-4,5,6,7,8,8a-hexahydro-5-hydroxy-2-methyl-2-oxo-, dimethyl ester

NCGC00385411-01_C24H28O10_Spiro[furan-3(2H),1(4H)-naphthalene]-4a,5(5H)-dicarboxylic acid, 6-(acetyloxy)-5-(3-furanyl)-4,5,6,7,8,8a-hexahydro-5-hydroxy-2-methyl-2-oxo-, dimethyl ester

C24H28O10 (476.16823880000004)

C21H32O12_Butanoic acid, 3-methyl-, (1aS,1bS,5S,5aS,6S,6aS)-2-[(beta-D-glucopyranosyloxy)methyl]-1a,1b,5,5a,6,6a-hexahydro-6-hydroxy-6-(hydroxymethyl)oxireno[3,4]cyclopenta[1,2-c]pyran-5-yl ester

NCGC00384998-01_C21H32O12_Butanoic acid, 3-methyl-, (1aS,1bS,5S,5aS,6S,6aS)-2-[(beta-D-glucopyranosyloxy)methyl]-1a,1b,5,5a,6,6a-hexahydro-6-hydroxy-6-(hydroxymethyl)oxireno[3,4]cyclopenta[1,2-c]pyran-5-yl ester

C21H32O12 (476.1893672)

[(1aS,1bS,5S,5aS,6S)-6-hydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1b,5,5a,6a-tetrahydro-1aH-oxireno[3,4]cyclopenta[1,3-d]pyran-5-yl] 3-methylbutanoate

[(1aS,1bS,5S,5aS,6S)-6-hydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1b,5,5a,6a-tetrahydro-1aH-oxireno[3,4]cyclopenta[1,3-d]pyran-5-yl] 3-methylbutanoate

C21H32O12 (476.1893672)

[(1aS,1bS,5S,5aS,6S)-6-hydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1b,5,5a,6a-tetrahydro-1aH-oxireno[3,4]cyclopenta[1,3-d]pyran-5-yl] 3-methylbutanoate_major

C21H32O12 (476.1893672)

[(1aS,1bS,5S,5aS,6S)-6-hydroxy-6-(hydroxymethyl)-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-1b,5,5a,6a-tetrahydro-1aH-oxireno[3,4]cyclopenta[1,3-d]pyran-5-yl] 3-methylbutanoate_53.3\\%

C21H32O12 (476.1893672)

Gly Asp Ala Asn Thr

C17H28N6O10 (476.18668279999997)

1-(2H-1,3-Benzodioxol-5-yl)-2-[2,6-dimethoxy-4-(prop-2-en-1-yl)phenoxy]propyl benzoate

C28H28O7 (476.1834938)

(+)-pantothenic acid calcium salt

C18H32CaN2O10 (476.16827620000004)

Tenofovir alafenamide

propan-2-yl (2S)-2-[[[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-phenoxyphosphoryl]amino]propanoate

C21H29N6O5P (476.1936954)

J - Antiinfectives for systemic use > J05 - Antivirals for systemic use > J05A - Direct acting antivirals > J05AF - Nucleoside and nucleotide reverse transcriptase inhibitors C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97452 - Nucleoside Reverse Transcriptase Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent

agrimonolide-6-O-glucopyranoside

C24H28O10 (476.16823880000004)

Calcium DL-Pantothenate

dl-pantothenic acid calcium salt

C18H32CaN2O10 (476.16827620000004)

H-Arg(Pbf)-OMe hydrochloride

C20H33ClN4O5S (476.1860078000001)

(2R)-2-[4-[(4-chlorophenyl)methyl]-5-methyl-1,2,4-triazol-3-yl]-N-[(4S)-7-cyano-3,4-dihydro-2H-chromen-4-yl]pyrrolidine-1-carboxamide

C25H25ClN6O2 (476.17274199999997)

tantalum (v) isopropoxide

C15H35O5Ta (476.19645)

C25H25ClN6O2

C25H25ClN6O2 (476.17274199999997)

Bis[4-(3-aminophenoxy)phenyl] phenylphosphine oxide

C30H25N2O2P (476.165356)

1H-Pyrazolo(4,3-d)pyrimidine-3-carboxamide, 1-(2-ethoxyethyl)-5-(ethylmethylamino)-7-((4-methyl-2-pyridinyl)amino)-N-(methylsulfonyl)

C20H28N8O4S (476.19541280000004)

1-[(6-Hydroxy-2-methyl-5-thiazolo[3,2-b][1,2,4]triazolyl)-(3,4,5-trimethoxyphenyl)methyl]-4-piperidinecarboxylic acid methyl ester

C22H28N4O6S (476.17294680000003)

N-{[2-({[1-(4-Carboxybutanoyl)amino]-2-phenylethyl}-hydroxyphosphinyl)oxy]acetyl}-2-phenylethylamine

C23H29N2O7P (476.1712294)

Calcium Pantothenate

C18H32CaN2O10 (476.16827620000004)

D - Dermatologicals > D03 - Preparations for treatment of wounds and ulcers > D03A - Cicatrizants A - Alimentary tract and metabolism > A11 - Vitamins D018977 - Micronutrients > D014815 - Vitamins

METHYLDOPA SESQUIHYDRATE

C20H32N2O11 (476.20060019999994)

D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D013565 - Sympatholytics D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D000322 - Adrenergic Agonists C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents C78272 - Agent Affecting Nervous System > C66884 - Dopamine Agonist

Tryptoquialanol

C25H24N4O6 (476.1695764)

(2R)-3-[(9S, 9aR)-9-hydroxy-2,2-dimethyl-3-oxo-1H,2H,3H,9H,9aH-imidazolidino[1,2-a]indol-9-yl]-2-(2-acetyl-4-oxo-3,4-dihydroquinazolin-3-yl)propanoic acid

C25H24N4O6 (476.1695764)

2-(2-Furanyl)-4-quinolinecarboxylic acid [2-[4-amino-1-methyl-3-(2-methylpropyl)-2,6-dioxo-5-pyrimidinyl]-2-oxoethyl] ester

C25H24N4O6 (476.1695764)

Loniphenyruviridoside A, (rel)-

ST 25:6;O4;S

C25H32O7S (476.1868642)

MT-7716 hydrochloride

C27H29ClN4O2 (476.1978924)

MT-7716 hydrochloride (W-212393 hydrochloride) is a selective non-peptide nociceptin receptor (NOP) agonist and promising potential treatment drug for alcohol abuse and relapse prevention[1].

(2s,3r,4s,5s,6r)-4,5-dihydroxy-2-[7-hydroxy-5-methyl-4-oxo-2-(2-oxopropyl)chromen-8-yl]-6-(hydroxymethyl)oxan-3-yl (2e)-2-methylbut-2-enoate

C24H28O10 (476.16823880000004)

[(1s,4as,5r,7as)-5-hydroxy-1-{[(2s,3s,4r,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1h,4ah,5h,7ah-cyclopenta[c]pyran-7-yl]methyl (2e)-3-phenylprop-2-enoate

C24H28O10 (476.16823880000004)

(2s,3's,3'ar,5'r,7'ar)-5'-[(1e)-5-(furan-3-yl)-2-methylpent-1-en-1-yl]-3',4,7'-trimethyl-5-oxo-1',2',3',3'a,5',7'a-hexahydrospiro[furan-2,4'-inden]-3-yloxidanesulfonic acid

C25H32O7S (476.1868642)

2-(4-allyl-2,6-dihydroxyphenoxy)-1-(3,4-dihydroxyphenyl)-1-propanol; (r,s)-form,3,4-methylene,3',5'-di-me ether,benzoyl

C28H28O7 (476.1834938)

{"Ingredient_id": "HBIN004285","Ingredient_name": "2-(4-allyl-2,6-dihydroxyphenoxy)-1-(3,4-dihydroxyphenyl)-1-propanol; (r*,s*)-form,3,4-methylene,3',5'-di-me ether,benzoyl","Alias": "NA","Ingredient_formula": "C28H28O7","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9059","PubChem_id": "NA","DrugBank_id": "NA"}

(2R,3R,4S,5R,6S)-3-isopropyl-2-methylol-6-(phenoxy)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-tetrahydropyran-3,4,5-triol

(2R,3R,4S,5R,6S)-2-(hydroxymethyl)-3-isopropyl-6-(phenoxy)-5-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]tetrahydropyran-3,4,5-triol; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-(phenoxy)-3-propan-2-yl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxane-3,4,5-triol; 134515-66-5; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-3-isopropyl-6-(phenoxy)-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-tetrahydropyran-3,4,5-triol; (2R,3R,4S,5R,6S)-2-(hydroxymethyl)-6-(phenoxy)-3-propan-2-yl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-oxane-3,4,5-triol

C21H32O12 (476.1893672)

C24H28O10 (476.16823880000004)

(3as,4s,5s,5ar,6r,9as,9bs)-5-[(2s,3s)-2,3-dimethyloxirane-2-carbonyloxy]-6-hydroxy-5a,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-4-yl (2r,3r)-2,3-dimethyloxirane-2-carboxylate

4,5,17-trihydroxy-14,18-dimethyl-6-methylidene-9,16-dioxo-3,10-dioxapentacyclo[9.8.0.0¹,⁷.0⁴,¹⁹.0¹³,¹⁸]nonadec-14-en-8-yl 2-methylbutanoate

C25H32O9 (476.2046222)

(3as,4s,5r,5ar,6r,9as,9bs)-5-[(2s,3r)-2,3-dimethyloxirane-2-carbonyloxy]-6-hydroxy-5a,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-4-yl (2s,3r)-2,3-dimethyloxirane-2-carboxylate